We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 30, 2020

Cost Implications for Annual FDA Oncology Drug Approvals

JAMA internal medicine


Additional Info

JAMA internal medicine
Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018
JAMA Intern Med 2020 Nov 09;[EPub Ahead of Print], PC DeMartino, MD Miljkovic, V Prasad

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading